Cargando…
Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid
The European Academy of Dermatology and Venerology (EADV) consensus states that the treatment of choice for bullous pemphigoid is systemic glucocorticosteroid therapy. Bearing in mind that long-term steroid therapy is associated with numerous side effects, an effective and safer treatment regimen fo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967290/ https://www.ncbi.nlm.nih.gov/pubmed/36836172 http://dx.doi.org/10.3390/jcm12041638 |
_version_ | 1784897227789959168 |
---|---|
author | Wojtczak, Magdalena Nolbrzak, Amanda Woźniacka, Anna Żebrowska, Agnieszka |
author_facet | Wojtczak, Magdalena Nolbrzak, Amanda Woźniacka, Anna Żebrowska, Agnieszka |
author_sort | Wojtczak, Magdalena |
collection | PubMed |
description | The European Academy of Dermatology and Venerology (EADV) consensus states that the treatment of choice for bullous pemphigoid is systemic glucocorticosteroid therapy. Bearing in mind that long-term steroid therapy is associated with numerous side effects, an effective and safer treatment regimen for these patients is still being sought. A retrospective analysis was performed of the medical reports of patients with diagnosed bullous pemphigoid. The study included 40 patients with moderate or severe disease, and who had continued ambulatory treatment for at least six months. The patients were divided into two groups: one treated with methotrexate in monotherapy, or with combined methotrexate and systemic steroid therapy. A slightly better survival rate was noted in the methotrexate group. No significant differences were observed between the groups in time to achieve clinical remission. The combination therapy group demonstrated more frequent disease recurrence and exacerbations during treatment, and a higher mortality rate. None of the patients in either group presented with severe side effects related to methotrexate treatment. The treatment of bullous pemphigoid with methotrexate in monotherapy is an effective and safe therapeutic method for elderly patients. |
format | Online Article Text |
id | pubmed-9967290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99672902023-02-26 Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid Wojtczak, Magdalena Nolbrzak, Amanda Woźniacka, Anna Żebrowska, Agnieszka J Clin Med Article The European Academy of Dermatology and Venerology (EADV) consensus states that the treatment of choice for bullous pemphigoid is systemic glucocorticosteroid therapy. Bearing in mind that long-term steroid therapy is associated with numerous side effects, an effective and safer treatment regimen for these patients is still being sought. A retrospective analysis was performed of the medical reports of patients with diagnosed bullous pemphigoid. The study included 40 patients with moderate or severe disease, and who had continued ambulatory treatment for at least six months. The patients were divided into two groups: one treated with methotrexate in monotherapy, or with combined methotrexate and systemic steroid therapy. A slightly better survival rate was noted in the methotrexate group. No significant differences were observed between the groups in time to achieve clinical remission. The combination therapy group demonstrated more frequent disease recurrence and exacerbations during treatment, and a higher mortality rate. None of the patients in either group presented with severe side effects related to methotrexate treatment. The treatment of bullous pemphigoid with methotrexate in monotherapy is an effective and safe therapeutic method for elderly patients. MDPI 2023-02-18 /pmc/articles/PMC9967290/ /pubmed/36836172 http://dx.doi.org/10.3390/jcm12041638 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wojtczak, Magdalena Nolbrzak, Amanda Woźniacka, Anna Żebrowska, Agnieszka Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid |
title | Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid |
title_full | Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid |
title_fullStr | Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid |
title_full_unstemmed | Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid |
title_short | Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid |
title_sort | can methotrexate be employed as monotherapy for bullous pemphigoid? analysis of efficiency and tolerance of methotrexate treatment in patients with bullous pemphigoid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967290/ https://www.ncbi.nlm.nih.gov/pubmed/36836172 http://dx.doi.org/10.3390/jcm12041638 |
work_keys_str_mv | AT wojtczakmagdalena canmethotrexatebeemployedasmonotherapyforbullouspemphigoidanalysisofefficiencyandtoleranceofmethotrexatetreatmentinpatientswithbullouspemphigoid AT nolbrzakamanda canmethotrexatebeemployedasmonotherapyforbullouspemphigoidanalysisofefficiencyandtoleranceofmethotrexatetreatmentinpatientswithbullouspemphigoid AT wozniackaanna canmethotrexatebeemployedasmonotherapyforbullouspemphigoidanalysisofefficiencyandtoleranceofmethotrexatetreatmentinpatientswithbullouspemphigoid AT zebrowskaagnieszka canmethotrexatebeemployedasmonotherapyforbullouspemphigoidanalysisofefficiencyandtoleranceofmethotrexatetreatmentinpatientswithbullouspemphigoid |